Evidence map›Paper›PMID 25013621›Full record

ArticleInternational journal of organ transplantation medicine2012

Human Bone Marrow-derived Mesenchymal Stem Cell: A Source for Cell-Based Therapy.

M Ayatollahi, B Geramizadeh, M Zakerinia, M Ramzi, R Yaghobi, P Hadadi, A R Rezvani, M Aghdai, N Azarpira, H Karimi

Abstract read
In one paragraph

Article in International journal of organ transplantation medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Expression of Concern for Ethyl Acetate Extract of Licorice Root (Iranian journal of pharmaceutical research : IJPR
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

M AyatollahiTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
B GeramizadehTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
M ZakeriniaHematology Research Center and Bone Marrow Transplantation Unit, Shiraz University of Medical Sciences, Shiraz, Iran.
M RamziHematology Research Center and Bone Marrow Transplantation Unit, Shiraz University of Medical Sciences, Shiraz, Iran.
R YaghobiTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
P HadadiTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
A R RezvaniHematology Research Center and Bone Marrow Transplantation Unit, Shiraz University of Medical Sciences, Shiraz, Iran.
M AghdaiTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
N AzarpiraTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
H KarimiTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe ability of mesenchymal stem cells (MSCs) to differentiate into many cell types, and modulate immune responses, makes them an attractive therapeutic tool for cell transplantation and tissue engineering.

objectiveThis project was designed for isolation, culture, and characterization of human marrow-derived MSCs based on the immunophenotypic markers and the differentiation potential.

methodsBone marrow of healthy donors was aspirated from the iliac crest. Mononuclear cells were layered over the Ficoll-Paque density-gradient and plated in tissue cultures dish. The adherent cells expanded rapidly and maintained with periodic passages until a relatively homogeneous population was established. The identification of adherent cells and the immune-surface markers was performed by flow cytometric analysis at the third passage. The in vitro differentiation of MSCs into osteoblast and adipocytes was also achieved.

resultsThe MSCs were CD11b (CR3), CD45, CD34, CD31 (PCAM-1), CD40, CD80 (B7-1), and HLA-class II negative because antigen expression was less than 5%, while they showed a high expression of CD90, and CD73. The differentiation of osteoblasts, is determined by deposition of a mineralized extracellular matrix in the culture plates that can be detected with Alizarin Red. Adipocytes were easily identified by their morphology and staining with Oil Red.

conclusionMSCs can be isolated and expanded from most healthy donors, providing for a source of cell-based therapy.

Indexed as

cell therapyHuman bone marrowMesenchymal stem cells

Identifiers

PMID25013621
PMCPMC4089277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.